Pioglitazone Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

47 API Suppliers, 26 USDMF, 10 CEP/COS, 10 JDMF, 17 EU WC, 26 KDMF, 16 NDC API, 14 Listed Suppliers, $ API Reference Price

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

160 FDF Dossiers, 77 FDA Orange Book, 36 Europe, 15 Canada, 2 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 15MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 45MG BASE, TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 850MG;EQ 15MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 16 SPI Pharma, 2 Seqens, 4 DKSH, 2 Jai Radhe Sales, 7 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 27 BASF, 2 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

88 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 41 Direct Compression, 32 Controlled & Modified Release, 32 Disintegrants & Superdisintegrants, 27 Solubilizers, 27 Thickeners and Stabilizers, 26 Granulation, 22 Co-Processed Excipients, 20 Topical, 20 Parenteral, 20 Lubricants & Glidants, 18 Film Formers & Plasticizers, 17 Taste Masking, 15 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 8 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 17 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 18 Finished Drug Prices

MARKET PLACE

11 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 9 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 6 JP, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21073 / DOSAGE - TABLET;ORAL - EQ 30MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
PIOGLITAZONE HYDROCHLORIDE(UNII: JQT35NPK6C) (PIOGLITAZONE - UNII:X4OV71U42S)	PIOGLITAZONE	45mg \| 30mg \| 15mg

Inactive Ingredients

Ingredient Name	A-S Medication Solutions	ACETRIS HEALTH, LLC	Actavis Pharma, Inc.	American Health Packaging	Aphena Pharma Solutions - Tennessee, LLC	Avera McKennan Hospital	Breckenridge Pharmaceutical, Inc.	Bryant Ranch Prepack	Cardinal Health	CELLTRION USA, INC.	Clinical Solutions Wholesale	Golden State Medical Supply	International Laboratories, LLC	Lake Erie Medical DBA Quality Care Products LLC	Macleods Pharmaceuticals Limited	NorthStar RxLLC	NuCare Pharmaceuticals,Inc.	PD-Rx Pharmaceuticals, Inc.	Preferred Pharmaceuticals Inc.	Proficient Rx LP	REMEDYREPACK INC.	RPK Pharmaceuticals, Inc.	Solco Healthcare LLC	Teva Pharmaceuticals USA Inc	Torrent Pharmaceuticals Limited	Mylan Institutional Inc.	Mylan Pharmaceuticals Inc.
CARBOXYMETHYLCELLULOSE CALCIUM(UTY7PDF93L)
HYDROXYMETHYL CELLULOSE(273FM27VK1)
HYDROXYPROPYL CELLULOSE (1200000 MW)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE (1200000 WAMW)(U3JF91U133)
HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE (45000 WAMW)(8VAB711C5E)
HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE (TYPE L)(UKE75GEA7F)
hydroxypropyl cellulose(RFW2ET671P)
HYDROXYPROPYL CELLULOSE, UNSPECIFIED(9XZ8H6N6OH)
lactose monohydrate(EWQ57Q8I5X)
MAGNESIUM STEARATE(70097M6I30)
MANNITOL(3OWL53L36A)
SODIUM LAURYL SULFATE(368GB5141J)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)

Drug Product Composition: Pioglitazone Hydrochloride